S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:MEMS

Matthews Emerging Markets Discovery Active ETF (MEMS) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free MEMS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$24.50
▼
$24.53
50-Day Range
N/A
52-Week Range
N/A
Volume
553 shs
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$5.95 million
Dividend Yield
N/A
Net Expense Ratio
0.89%
Stock AnalysisHeadlinesHoldingsSocial Media
MEMS stock logo

About Matthews Emerging Markets Discovery Active ETF (NASDAQ:MEMS)

MEMSIC, Inc. provides advanced semiconductor sensor and system solutions based on integrated micro electro-mechanical systems (MEMS), technology and mixed signal circuit design. The Company operates in two segments: semiconductor sensor products and sensor system solution products. Its semiconductor sensor products, which is based on MEMS technology and advanced, integrated circuit design. Its sensor system solution products, which incorporate sensors with on-board computing, wireless communications and systems and application software solutions. The Company manufactures its sensor products utilizing a semi-fabless model by outsourcing the production of complementary metal-oxide semiconductor (CMOS) wafers and completing the post-CMOS MEMS process in-house. In September 2013, the Company announced the completion of the merger with MZ Investment Holdings Limited (Parent) and the Company continuing as the surviving company after the merger as a wholly owned subsidiary of Parent.

MEMS ETF News Headlines

March 1, 2024 | morningstar.com
Matthews EM Sm Coms Inv
February 24, 2024 | finance.yahoo.com
Matthews Emerging Markets Discovery Active ETF (MEMS)
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 23, 2024 | benzinga.com
Matthews International Funds Matthews Pacific Tiger Active ETF (ARCA:ASIA) Dividends: History, Yield and Dates
October 26, 2023 | benzinga.com
Magnetic Sensor Market Size Is Projected to Grow at A CAGR Of 6.68% By 2030, Powered by Rising Investments and Notable Technological Advancements
October 16, 2023 | investing.com
MEMS Historical Data
September 25, 2023 | msn.com
Trivia with Trevonius Monk at Sanitas Brewing and other events for today
May 24, 2023 | health.usnews.com
Los Robles Hospital and Medical Center
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
May 17, 2023 | marketwatch.com
Wireless Sensor Networks (WSN) Market Upto 2030
See More Headlines
Receive MEMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Matthews Emerging Markets Discovery Active ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Matthews International Capital Management
Fund Name
Matthews Emerging Markets Discovery Active ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:MEMS
Inception Date
1/10/2024
Fund Manager
Vivek Tanneru, Jeremy Sutch, Alex Zarechnak
Web
www.memsic.com
Phone
+1-978-7380900

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Size and Style
Focus
Small & Mid Caps
Development Level
Emerging Markets
Region
Emerging Markets
Number of Holdings
77

Fund Statistics

Assets Under Management
$5.95 million
Average Daily Volume
$0.00
Discount/Premium
0.05%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Matthews International Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Funds Distributors LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Miscellaneous

Outstanding Shares
N/A
Beta
N/A
Creation Fee
$250.00
These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Matthews Emerging Markets Discovery Active ETF Expenses

TypeMEMSSmall & Mid Caps ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.58%0.54%0.48%0.51%
Other Expenses0.00%0.51%0.54%0.34%0.58%
Total Expense0.99%0.72%0.70%0.58%0.70%
Fee Waiver-0.10%-0.54%-0.55%-0.22%-0.57%
Net Expense0.89%0.57%0.60%0.54%0.58%

Matthews Emerging Markets Discovery Active ETF (MEMS) Exposure

MEMS Sector Exposure

MEMS Industry Exposure

Full Holdings Details

MEMS ETF - Frequently Asked Questions

What does MEMS invest in?

Matthews Emerging Markets Discovery Active ETF is a equity fund issued by Matthews International Capital Management. MEMS focuses on small & mid caps investments. The fund's investments total to approximately $5.95 million assets under management.

What is the management fee for Matthews Emerging Markets Discovery Active ETF?

Matthews Emerging Markets Discovery Active ETF's management fee is 0.99% and has no other recorded expenses. However, MEMS has a fee waiver of -0.10% to reimburse the expenses. The net expense ratio for MEMS is 0.89%.

What other stocks do shareholders of Matthews Emerging Markets Discovery Active ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Matthews Emerging Markets Discovery Active ETF investors own include Aurora Cannabis (ACB), Kroger (KR), Biopharmx (BPMX), China Railway Group (CRWOF), Denali Therapeutics (DNLI), iShares MSCI Italy ETF (EWI), Nokia Oyj (NOK), Transnational Cannabis (WLDCF), Johnson Controls International (JCI) and General Electric (GE).

This page (NASDAQ:MEMS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media